GlassScriptPhysician profile
Alan Nerenberg
NPI 1790089464
$2,590.74
in general payments reported to CMS, 2019-2025
16 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $210 · 2021: $240 · 2022: $641 · 2023: $345 · 2024: $420 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.83 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $960.41 | 2019-2023 | |
| Therapeuticsmd, INC. | $266.34 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $216.01 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $215.31 | 2021-2024 | |
| Amgen INC. | $210.94 | 2025 | Evenity |
| Lupin INC. | $163.93 | 2019-2020 | |
| Astellas Pharma US INC | $157.85 | 2023-2024 | Veozah |
| Organon LLC | $101.73 | 2023-2024 | Jada System |
| Exeltis, USA INC. | $75.67 | 2024 | Slynd |
| Scynexis, INC. | $75.21 | 2022 | |
| Vertical Pharmaceuticals, LLC | $35.04 | 2019 | |
| Avion Pharmaceuticals | $33.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $24.96 | 2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $21.73 | 2024 | Aptima |
| Amag Pharmaceuticals, INC. | $19.05 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Nerenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.